Evolus, Inc. (LON:0K16)
14.58
+0.43 (3.00%)
At close: Jan 31, 2025
Evolus Market Cap
Evolus has a market cap or net worth of 203.66 million as of February 12, 2026. Its market cap has decreased by -71.89% in one year.
Market Cap
203.66M
Enterprise Value
285.42M
Revenue
212.64M
Ranking
n/a
PE Ratio
n/a
Stock Price
14.58
Market Cap Chart
Since February 8, 2018, Evolus's market cap has increased from 194.93M to 203.66M, an increase of 4.48%. That is a compound annual growth rate of 0.55%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Feb 11, 2026 | 204.28M | -36.22% |
| Dec 31, 2025 | 320.27M | -42.64% |
| Dec 31, 2024 | 558.40M | 16.94% |
| Dec 29, 2023 | 477.50M | 36.20% |
| Dec 30, 2022 | 350.58M | 31.20% |
| Dec 31, 2021 | 267.20M | 221.71% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Feb 8, 2018 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| AstraZeneca | 231.18B |
| GSK plc | 86.28B |
| Haleon | 36.22B |
| Smith & Nephew | 11.10B |
| NIOX Group | 272.49M |
| Integrated Diagnostics Holdings | 266.72M |
| Avacta Group | 260.26M |
| Tristel | 203.19M |